It looks like the new Endurace but with bigger tyres ...

GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced that company management will present at the BofA Securities 2026 Health ...

Grail is partnering with Samsung to move into Asia. The innovative cancer test maker just got major new sources of funding. Well, Grail makes a multicancer early-detection test called Galleri that ...

Early cancer detection is highly beneficial to sufferers, and Grail's Galleri test offers a solution. The company is the leader in the race for FDA approval, but it could benefit from being part of a ...

Illumina (ILMN +1.34%) spun off liquid biopsy company GRAIL a few years ago. But the big genomic sequencing pioneer now wants GRAIL back. However, there's a potential wrinkle that could derail ...

Even the company's name conveys an element of hubris: Grail, as in, the holy grail of medicine. This particular grail? To create a blood test that can detect cancer early enough to treat it. And Grail ...